Live Status Check

NCT00107289 Recruiting Status

Real-time enrollment status for this neuroblastoma clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 2:21 PM UTC

NCT00107289 Status Summary

NCT NumberNCT00107289
Recruiting StatusRecruiting
ConditionNeuroblastoma
PhaseClinical Trial
Target Enrollment200 participants
Active Locations1 sites in the US
SponsorMemorial Sloan Kettering Cancer Center
Last Updated on CT.govMay 29, 2026 (May 29, 2026)

About NCT00107289 Enrollment Status

As of July 13, 2026: Clinical trial NCT00107289 is currently recruiting participants. This clinical trial study for neuroblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT00107289

Is NCT00107289 still recruiting?

Yes, NCT00107289 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT00107289 recruiting?

This trial is recruiting at 1 location in the United States. View all available locations on the full study page.

How do I enroll in NCT00107289?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT00107289 status last updated?

The official ClinicalTrials.gov record for NCT00107289 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial